Description: Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. The company's platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo has also actively supported a number of COVID-19 response efforts, including K-12 pooled testing, vaccine manufacturing optimization and therapeutics discovery.
Home Page: www.ginkgobioworks.com
DNA Technical Analysis
27 Drydock Avenue
Boston,
MA
02210
United States
Phone:
877 422 5362
Officers
| Name | Title |
|---|---|
| Dr. Jason Kelly | Founder, CEO & Director |
| Dr. Reshma P. Shetty | Founder, Pres, COO & Director |
| Mr. Mark E. Dmytruk | Chief Financial Officer |
| Mr. Thomas Knight Jr. | Founder |
| Mr. Austin Che | Founder, Head of Strategy & Treasurer |
| Mr. Bartholomew Canton | Founder, CTO & Sec. |
| Marie E Fallon | Chief Accounting Officer |
| Karen Tepichin | Gen. Counsel & Sec. |
| Ms. Anna Marie Wagner | Sr. VP of Corp. Devel. |
| Ms. Samantha Sutton | Head of People |
Exchange: NYSE
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 2.4609 |
| Price-to-Sales TTM: | 5.9899 |
| IPO Date: | 2021-04-19 |
| Fiscal Year End: | December |
| Full Time Employees: | 641 |